YYZ Pharmatech Inc. is a private life sciences company founded in Toronto, Canada in 2004. YYZ invents and develops diagnostic and therapeutic technology for use in modern pharmaceuticals, with breakthroughs in the discovery and ultra-sensitive quantification of biomolecules. YYZ’s technology platform includes the patented ELiMSA method (Enzyme Linked Mass Spectrometric Assay). ELiMSA combines enzyme amplification with detection by mass spectrometry to achieve industry-leading sensitivity, quantification and reliability in identifying biomolecules.